Aimco Pesticides Q2 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
N/A
Order
N/A
Capex
Yes
1 of 3 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
Category 3- Target revenue for FY26: Over ₹210 crore (Ashit Dave on Q4 and FY26 outlook).
- Brand business revenue target for FY26: ₹200 crore (aim to double in two years).
- Volume growth expectation: 15-20% increase year-on-year.
- Export to domestic sales ratio currently ~50:50, with expectation of export business improvement in FY26.
- New products: Three recently commercialized molecules expected to generate significant revenue from next financial year.
- Capacity utilization: Currently around 70%, with plans to repurpose insecticide plant and consider additional capacity in Q4 FY25.
- Bifenthrin capacity to be fully utilized in next two financial years, driven by Brazil market entry.
- Overall growth dependent on pricing, market conditions, and regulatory registrations, especially in Brazil.
- EBITDA margin expected to remain stable or improve with new high-margin branded products.
See what Aimco Pesticides management said on margin guidance — free account, 30 seconds.
Fundraise plans
- Currently, there is no mention of any ongoing or planned fundraising through debt or equity.
- The company has put major Capex plans on hold to avoid burdening cash flow during difficult times.
- Future Capex decisions, including investments in additional manufacturing capacity, will be taken cautiously after stabilizing profitability and margins.
- Any large investments or capacity expansions will be evaluated and decided by the board at appropriate times.
- No specific plans for raising funds via equity or debt have been disclosed for FY25 or FY26.
See what Aimco Pesticides management said on order book — free account, 30 seconds.
Capex plans
Yes- Current Capex is on hold to avoid burdening cash flow during difficult times; focus is on stabilizing existing business first.
- Planned Capex for FY25 includes ₹1.5 to 2 crores to repurpose existing manufacturing facilities for a new product (modification and debottlenecking).
- Major Capex proposals (formulation plant and intermediate plant with ~2000 tons capacity) have been deferred to FY26 or beyond, pending profitability and margin improvement.
- Two new formulation plants have been acquired; setting up of a new formulation plant expected next year to add capacity, not to shift existing plant.
- Additional capacity decisions for three new molecules will be made in Q4 FY25 based on market conditions.
- Large-scale capacity expansions for new products anticipated in FY26 after product registrations and market demand improve.
- Board to evaluate and approve any major future plant capacity investments carefully.
Track Aimco Pesticides — get its next earnings analysis in your feed
Margin guidance
Category 3- Aimco Pesticides expects to be profitable by the end of FY25, with improving Q3 and Q4 performance.
- Revenue target for FY25 is over ₹210 crore, with EBITDA margins expected to improve, though Q4 pricing remains uncertain.
- For FY26, a clearer revenue and EBITDA margin target will be shared next quarter; branded business aims for ₹200 crore revenue by FY26.
- The company plans 15-20% volume growth annually over the next couple of years, aided by new product launches and export market expansion.
- Gross margins for branded formulations are stable at 30-35%, with EBITDA margins around 10%, expected to sustain as product mix improves.
- New products commercial ramp-up and export registrations (e.g., Triclopyr in Brazil in FY26) should enhance growth.
- Capex remains cautious to preserve cash flow, focusing on repurposing existing plants for new products with major capacity expansions deferred till profitability stabilizes.
Order book
- Significant orders are ongoing in Q3, with volume-wise expectations being satisfactory.
- Q4 order projections are uncertain due to pricing and supply issues, especially from China.
- Negotiations for new export contract products, including a herbicide, are ongoing but not finalized.
- Discussions for Bifenthrin volumes in Brazil are active, expecting significant volume in Q4 and full capacity utilization by FY26.
- Three new products are commercialized and early stage sales have started; significant ramp-up expected in next financial year.
- The company's export orderbook faces pressure from price erosion and competition but volume remains steady.
- Domestic brand business order momentum is strong and growing with expected revenue of ₹130 crore for FY25 and ₹200 crore by FY26.
- Additional capacity decisions for new molecules pending and to be finalized next quarter.
How does Aimco Pesticides rank vs peers in Fertilizers & Agrochemicals?
Pro featureHow does Aimco Pesticides rank in Fertilizers & Agrochemicals?
Compare Aimco Pesticides against every Fertilizers & Agrochemicals company (Q2 FY25) on revenue, margins and earnings-call signals.
Continue your research
What Aimco Pesticides's management said in earlier quarters
Others in Fertilizers & Agrochemicals this season
- GSP Crop Science (Q1 FY27)
Capacity utilization indicates room for growth: 70-75% for technical and 25-30% for formulations. Key concall takeaways from GSP Crop Science Ltd's Q1 FY27…
- Sharda Cropchem (Q4 FY25)
Globally, the company’s current 4%-5% global market share offers scope to increase, meaning a 1% global share gain equates to 20%-25% volume growth for them…
- Sumitomo Chemi. (Q2 FY26)
Domestic sales grew 11% YoY in H1 FY '25-'26, with improved farmer connect initiatives like 'Every Day Farmers Day' enhancing demand. Key concall takeaways…
- Indogulf Cropsci (Q3 FY26)
The value of these export orders in hand is approximately INR 4 to 5 crores. Key concall takeaways from Indogulf Cropsci's Q3 FY26 earnings call — and how it…